Patents by Inventor Dahee Yoon

Dahee Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kit for tracking and diagnosing degree of progressive chronic hepatitis and liver fibrosis by measuring asialo (alpha)1-acid glycoprotein as hepatocellular injury marker and use thereof
    Patent number: 11493521
    Abstract: Exemplary embodiments of the present invention relate to rapidly and easily test initial liver disease and more particularly to a monoclonal antibody for ?1-acid glycoprotein, a diagnosis kit for tracking progressive chronic hepatitis and liver fibrosis in an initial phase of liver disease by measuring the concentration of asialo-?1-acid glycoprotein (AsAGP) as a hepatocyte injury marker in a sample using the antibody, and a use thereof. Further, embodiments of the present invention provide a kit for specifically determining the degree of progressive chronic hepatitis and hepatic fibrosis from a blood sample and an immunochromatography strip, comprising a HRP-RCA II (Ricinus communis agglutinin II) conjugate or a Gold-RCA II conjugate specifically binding to asialo ?-1 acid glycoprotein.
    Type: Grant
    Filed: January 18, 2020
    Date of Patent: November 8, 2022
    Inventors: WangJo Cha, Hyunhyo Suh, Mikyung Chung, Jae-hyun Cho, Mi Sook Jeong, Dahee Yoon, Myung Hun Lee, Sunghong Kim, Pil Sang Park
  • KIT FOR TRACKING AND DIAGNOSING DEGREE OF PROGRESSIVE CHRONIC HEPATITIS AND LIVER FIBROSIS BY MEASURING ASIALO (alpha)1-ACID GLYCOPROTEIN AS HEPATOCELLULAR INJURY MARKER AND USE THEREOF
    Publication number: 20210132082
    Abstract: Exemplary embodiments of the present invention relate to rapidly and easily test initial liver disease and more particularly to a monoclonal antibody for ?1-acid glycoprotein, a diagnosis kit for tracking progressive chronic hepatitis and liver fibrosis in an initial phase of liver disease by measuring the concentration of asialo-?1-acid glycoprotein (AsAGP) as a hepatocyte injury marker in a sample using the antibody, and a use thereof. Further, embodiments of the present invention provide a kit for specifically determining the degree of progressive chronic hepatitis and hepatic fibrosis from a blood sample and an immunochromatography strip, comprising a HRP-RCA II (Ricinus communis agglutinin II) conjugate or a Gold-RCA II conjugate specifically binding to asialo ?-1 acid glycoprotein.
    Type: Application
    Filed: January 18, 2020
    Publication date: May 6, 2021
    Inventors: WangJo Cha, Hyunhyo Suh, Mikyung Chung, Jae-hyun Cho, Mi Sook Jeong, Dahee Yoon, Myung Hun Lee, Sunghong Kim, Pil Sang Park